StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) stock

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30
$2.71+0.04 (+1.50%)

Close on Nov 18, 2026Market cap $94.21MP/E –Yield –

Anixa Biosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Anixa Biosciences's profit margin for the twelve months ending Oct 31, 2023 was -4671.9%. For fiscal 2024 it was -5978.1%, against -4671.9% the year before. The highest annual figure on record is -14.9% in fiscal 2015.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2024Oct 31, 2024-5978.1%−1306.2
FY2023Oct 31, 2023-4671.9%−2141.8
FY2021Oct 31, 2021-2530.1%+2128.7
FY2019Oct 31, 2019-4658.8%−3400.8
FY2018Oct 31, 2018-1258.1%+123.7
FY2017Oct 31, 2017-1381.8%+290.4
FY2016Oct 31, 2016-1672.1%−1657.2
FY2015Oct 31, 2015-14.9%+247.0
FY2014Oct 31, 2014-261.9%+2330.3
FY2013Oct 31, 2013-2592.3%−2139.9
FY2012Oct 31, 2012-452.4%+283.0
FY2011Oct 31, 2011-735.5%−27.2
FY2010Oct 31, 2010-708.3%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q2 FY2023CQ1 2023Apr 30, 2023-1089.5%−905.7
Q1 FY2022CQ4 2021Jan 31, 2022-746.4%−251.4
Q1 FY2021CQ4 2020Jan 31, 2021-430.4%+93.4
Q3 FY2018CQ2 2018Jul 31, 2018-1510.9%–
Q2 FY2018CQ1 2018Apr 30, 2018-183.8%–
Q3 FY2017CQ2 2017Jul 31, 2017-495.0%–
Q4 FY2016CQ3 2016Oct 31, 2016-523.8%–

More Anixa Biosciences figures

See a number that looks wrong?